- Report
- May 2025
- 120 Pages
Global
From €4234EUR$4,750USD£3,661GBP
- Report
- July 2024
- 208 Pages
Global
From €5348EUR$6,000USD£4,625GBP
- Report
- July 2024
- 120 Pages
Global
From €4234EUR$4,750USD£3,661GBP
- Report
- February 2024
- 120 Pages
Global
From €4234EUR$4,750USD£3,661GBP
- Report
- February 2024
- 179 Pages
Global
From €4234EUR$4,750USD£3,661GBP
- Report
- April 2023
- 115 Pages
Global
From €4234EUR$4,750USD£3,661GBP
- Report
- January 2024
- 110 Pages
Global
From €4011EUR$4,500USD£3,469GBP
- Report
- June 2024
- 140 Pages
Asia Pacific
From €3449EUR$3,869USD£2,982GBP
- Report
- April 2025
- 203 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- May 2024
- 191 Pages
Global
From €2228EUR$2,500USD£1,927GBP
- Report
- May 2024
- 140 Pages
Global
From €4412EUR$4,949USD£3,815GBP
- Report
- May 2023
- 147 Pages
Global
From €4412EUR$4,949USD£3,815GBP
- Report
- April 2025
- 145 Pages
Global
From €3521EUR$3,950USD£3,045GBP
- Report
- February 2025
- 149 Pages
Global
From €3521EUR$3,950USD£3,045GBP
- Report
- April 2024
- 121 Pages
Global
From €3521EUR$3,950USD£3,045GBP
- Report
- March 2025
- 120 Pages
North America
From €3075EUR$3,450USD£2,659GBP
- Report
- March 2025
- 140 Pages
From €3075EUR$3,450USD£2,659GBP
- Report
- March 2025
- 153 Pages
Europe
From €3075EUR$3,450USD£2,659GBP
- Report
- March 2025
- 152 Pages
Asia Pacific
From €3075EUR$3,450USD£2,659GBP
- Report
- March 2025
- 143 Pages
Middle East, Africa
From €3075EUR$3,450USD£2,659GBP

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more